Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

AM-1401 available for licensing

Oct. 25, 1996

Expanded access program allowed for Remune

Oct. 25, 1996

Nucleotide analogue enters clinical trials for HIV

Oct. 25, 1996

Water-soluble prodrug of HIV protease inhibitor reported by DuPont Merck

Oct. 25, 1996

Torii prepares agents for HIV infection

Oct. 25, 1996

Buckminsterfullerene inventors receive Nobel Prize in Chemistry

Oct. 18, 1996

South and Central American development and distribution agreement for Remune

Oct. 18, 1996

Pivotal trial of thalidomide in AIDS patients completed

Oct. 18, 1996

Norvir now available in U.K.

Oct. 18, 1996

Shionogi begins clinical trials with novel reverse transcriptase inhibitor

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...